Amitriptylinoxide

DB13114ApprovedWithdrawnSmall molecule

Amitriptylinoxide is a tricyclic antidepressant indicated in the treatment of depressive disorders. Amitriptylinoxide has been used in trials studying Major Depression.

Formula / weight: C₂₀H₂₃NO · 293.41 g/mol (avg)
Also known as: Amitriptyline oxide
Code names: J9.621K

Resolves to

Compound

UNIITYR2U59WMACAS4317-14-0ChEMBLCHEMBL627ChEBI135224PubChem20313

Clinical / RWD

RxNorm236734

Structure

InChIKeyZPMKQFOGINQDAM-UHFFFAOYSA-NSMILESCN(C)(=O)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12

What you can answer from here — as of May 10, 2025

1,354Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

20ContraindicationsEach with its own population and attribute set

12Marketed productsAcross every region we cover

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Amitriptylinoxide, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account